ITGR · Integer Holdings Corp

Track ITGR — free

$126.38 +0.10 (+0.08%)

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$4.30B

33.99M

Up next

Next earnings call

Nov 9, 2026 Est · unconfirmed · in 7 wks

Latest filing: 10-Q

filed Aug 4, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$1.84B

Trailing 12 months

Net income (TTM)

$128.40M

Trailing 12 months

Revenue growth YoY

-2.6%

Year over year

Operating margin

9.7%

Trailing 12 months

P / E (TTM)

34.3

Trailing earnings · reciprocal yield 2.9%

FCF yield

2.6%

TTM · current market cap

Return on invested capital

5.7%

Trailing 12 months

Net cash

−$1.22B

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

-4.4%

Year over year · fewer shares

Price change (1Y)

+21.4%

Trailing year

Short interest

7.6%

Latest settlement · 3.9 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Fair Quant / Vol High

Market backdrop VIX 14.8 · calm Equity put/call 0.58

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +35%

above

Price vs 50-day avg +8%

above

RSI (14) 76

overbought

MACD trend Negative

52-week position 100%

near high

Momentum

relative strength

Very Strong

1-month return +1%

trailing

6-month return +48%

trailing

YTD return +61%

this year

Relative strength +28%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $117 › 200d $93 — 50d above 200d

Institutional flow Accumulating

+2% holders QoQ · +47 funds added

Insider flow Distributing

Net -$5.2M over 90 days · 100% sells

Short interest Falling

7.64% of float · ▼ -9.0% MoM · 3.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

332 holders — mid 3-yr range

Squeeze score 55

elevated · 0–100

Fundamentals

Fair

Revenue growth +8%

Y/Y

Gross margin 27%

expanding

EPS growth −14%

Y/Y

Free cash flow $105.1M

Valuation P/E 34.3

in line

Buyback $100.0M

remaining

Balance sheet $1.2B

net debt

Quant / Vol

risk profile

High

Volatility 47%

annualized · 1-yr

Max drawdown −42%

past year

ATR 0.6%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Beat or met 2 of last 3

Latest guidance · from the 8-K filed Apr 30, 2026

Sales · 2026 $1.81B – $1.84B

prior FY $1.85B midpoint −1.8% Y/Y

Adjusted operating income · 2026 $285M – $305M

Operating income · 2026 $165M – $185M

EBITDA · 2026 $375M – $399M

Cash flow from operating activities · 2026 $185M – $205M

Adjusted total interest expense · 2026 $38M – $40M

Prior guidance period ended · from the 8-K filed Jul 25, 2024

Sales · 2024 Outlook $1.74B – $1.77B

Operating income · 2024 Outlook $202M – $220M

Adjusted operating income · 2024 Outlook $275M – $293M

Adjusted net income · 2024 Outlook $174M – $189M

Net income · 2024 Outlook $116M – $130M

Adjusted EBITDA · 2024 Outlook $357M – $377M

Depreciation and amortization · 2024 Outlook $106M – $114M

Cash flow from operating activities · 2024 Outlook $185M – $205M

Adjusted total interest expense · 2024 Outlook $58M – $61M

Adjusted effective tax rate · 2024 Outlook 18% – 20%

Stock-based compensation · 2024 Outlook $24M – $27M

Cash income tax payments · 2024 Outlook $38M – $42M

Guided vs delivered · last 3 settled

Sales 2024 Outlook

guided $1.74B – $1.77B

guided $1.74B – $1.77B $1.72B Miss −2.0%

Sales 2021

guided $1.21B – $1.22B

guided $1.21B – $1.22B $1.22B Beat +0.7%

Sales first quarter of 2021

guided $280M – $290M

guided $280M – $290M $290.47M Beat +1.9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

2 · 1 · 3

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+35% Bullish

Price vs 50-day avg

+8% Bullish

RSI (14)

76 Bearish

MACD trend

Negative Bearish

52-week position

100% Bullish

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) No cross

50d $117 › 200d $93 — 50d above 200d

Institutional flow Accumulating

+2% holders QoQ · +47 funds added

Insider flow Distributing

Net -$5.2M over 90 days · 100% sells

Short interest Falling

7.64% of float · ▼ -9.0% MoM · 3.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

332 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $63 Now $126 · 100% Range high $127

vs 200-day avg +35% vs 50-day avg +8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
ITGR Integer Holdings Corp this stock	$4.30B	+61.0%	+8.0%	34.3	7.6%
ABT Abbott Laboratories	$178.73B	-18.1%	+5.7%	28.7	1.3%
MDT Medtronic plc	$117.85B	-4.1%	+8.4%	22.7	0.9%
SYK Stryker Corp	$105.53B	-21.7%	+11.2%	28.5	2.0%
BSX Boston Scientific Corp	$64.27B	-54.5%	+12.5%	18.0	3.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

332

% held: 122.4%
Net QoQ: +1.5M sh
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

331

View

Short & Settlement

Short Interest Falling

Shares short

2.6M

Days to cover: 3.9d
Change: -255.5K sh

View

Short Volume

Short vol %

74%

As of: Sep 18, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $125
As of: Aug 24, 2026

View

Off-Exchange

Off-exchange %

49.0%

Week of: Aug 17, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$5.2M

Buyers / Sellers: 0 / 2

Buyers Sellers

View

Financials

Revenue (FY)

$1.9B

Net income (FY): $102.8M
EPS diluted: $2.89

View

Buybacks

Authorized · 2 programs

$250.0M

Remaining: $100.0M

Spent Remaining

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 4, 2026
This year: 13

View

Proposed Sales

Value

$593.6K

Shares: 4.7K
Filed: Sep 15, 2026

View

Earnings & Events

Earnings Calls

Last call

Aug 6, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
ITGR	+0.2%	+0.9%	+48.0%	+0.8%	+61.0%
SPY	-0.3%	-0.1%	+20.1%	-0.7%	+11.7%
vs SPY	+0.6%	+1.0%	+27.9%	+1.5%	+49.3%

Capital returns

Buyback programs · 2 active · as of Jul 3, 2026

Authorized (total)

$250.00M

Spent (derived)

$150.00M

Remaining

$100.00M

Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1114483 CUSIP 45826H109 13F (30d) 13 filings 10 filers Visit website Investor relations

ITGR · Integer Holdings Corp

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns